Business Context and Reporting Period
This Form 8-K is a current report filed by Amedica Corporation (not Sintx Technologies, Inc.) on June 1, 2015. The filing addresses "Other Events" related to the status of a secondary offering completed on November 26, 2014.
Key Financial Metrics and Capital Structure
The filing provides specific data regarding equity issuance and warrant exercises but does not report revenue, profit, cash flow, margins, debt, or liquidity metrics.
- Secondary Offering Units Sold: 11,441,646 units at $1.14 per unit.
- Total Warrants Issued: 13,157,892 (including 1,716,246 from over-allotment).
- Warrants Exercised (Cashless): 11,742,569 warrants.
- Shares Issued from Exercise: 34,951,816 shares of common stock.
- Remaining Warrants Outstanding: 1,415,323.
- Total Common Stock Outstanding: 62,467,441 shares.
Material Changes
The primary material change reported is the significant increase in outstanding common stock due to the cashless exercise of a majority of the warrants issued in the November 2014 secondary offering. The filing does not provide comparative financial data to assess changes in revenue or profitability versus prior periods.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors beyond the disclosure of the capital structure changes. No unusual items or contingencies are described in this report.
Investor Verification Checklist
- Verify the company name is Amedica Corporation, as the input metadata incorrectly referenced Sintx Technologies, Inc.
- Confirm the impact of the 34,951,816 newly issued shares on existing shareholder dilution.
- Review the terms of the remaining 1,415,323 outstanding warrants for potential future dilution.
- Check subsequent filings for financial performance data, as this 8-K does not contain revenue or earnings figures.